Zhang, Xu-Feng <br/><br/>
A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.  [electronic resource] 

 -  Neuropharmacology  Sep 2010 
 - 201-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2010.05.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biophysics<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Electric Stimulation--methods<br/>Ganglia, Spinal--cytology<br/>Humans<br/>Hyperalgesia--drug therapy<br/>Male<br/>Membrane Potentials--drug effects<br/>Morpholines--chemistry<br/>NAV1.8 Voltage-Gated Sodium Channel<br/>Neuralgia--complications<br/>Niacinamide--analogs & derivatives<br/>Pain Threshold--drug effects<br/>Patch-Clamp Techniques--methods<br/>Rats<br/>Rats, Sprague-Dawley<br/>Sensory Receptor Cells--drug effects<br/>Sodium Channel Blockers--chemistry<br/>Sodium Channels--drug effects<br/>Spinal Cord Injuries--complications<br/>Tetrodotoxin--pharmacology<br/>Transfection--methods